Company Filing History:
2 out of 2 
1 out of 1 
1 out of 832,912 Years Active: 2003-2021
Title: Innovations of Hang-Cheol Shin
Introduction
Hang-Cheol Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of stable growth factor mutants. With a total of 4 patents, his work has the potential to revolutionize the cosmetic and pharmaceutical industries.
Latest Patents
Among his latest patents is the invention of a human fibroblast growth factor-2 mutant with increased stability. This highly stable basic fibroblast growth factor (bFGF) mutant is designed to maintain its activity even during distribution and storage. The patent details a method of producing the bFGF mutant, which includes a DNA base sequence encoding the mutant, an expression vector, and a transformant. Another notable patent involves highly stabilized epidermal growth factor mutants, which also exhibit excellent thermal stability and are suitable for use in functional cosmetics and skin regeneration products.
Career Highlights
Hang-Cheol Shin has worked with Pnp Biopharm Co., Ltd., where he has contributed to various innovative projects. His expertise in biotechnology has allowed him to develop products that maintain their efficacy over time, addressing a significant challenge in the industry.
Collaborations
Some of his notable coworkers include Hyun Chul Lee and Su-Jin Kim, who have collaborated with him on various research initiatives.
Conclusion
Hang-Cheol Shin's innovative work in the field of biotechnology, particularly with growth factor mutants, showcases his commitment to advancing the industry. His patents reflect a deep understanding of stability and efficacy, paving the way for future developments in cosmetics and medicine.